[EN] OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS<br/>[FR] INHIBITEURS D'OXADIAZOLYL DIHYDROPYRANO[2,3-B] PYRIDINE DE HIPK2 POUR LE TRAITEMENT DE LA FIBROSE RÉNALE
申请人:ICAHN SCHOOL MED MOUNT SINAI
公开号:WO2022173795A1
公开(公告)日:2022-08-18
Compounds that are selective inhibitors of Smad3 activation are disclosed. The compounds are (3-aryl-1,2,4-oxadiazol-5-yl)-3,4-dihydro-2H-pyrano[2,3-b]pyridines of structure (I), in which Ar is aryl or heteroaryl. The compounds disclosed are useful in treatment of fibrotic disease, particularly renal fibrosis, and similar diseases associated with the dysregulation of the HIPK2/Smad3 signaling pathway.
本文揭示了一种选择性抑制Smad3激活的化合物。这些化合物是结构式(I)中的(3-芳基-1,2,4-噁二唑-5-基)-3,4-二氢-2H-吡喃[2,3-b]吡啶,其中Ar是芳基或杂环芳基。所揭示的这些化合物在治疗纤维化疾病,特别是肾脏纤维化以及与HIPK2/Smad3信号通路失调相关的类似疾病中具有用途。